Table 2. Demographic characteristics of vaccinated participants.
| Mean ± SD | Range (min-max) |
|||
|---|---|---|---|---|
| Gender | N | (years) | (years) | |
| Group 1 | Men Women Total |
14 16 30 |
22.9 ± 4.1 22.5 ± 5.0 22.7 ± 4.5 |
18–36 19–39 18–39 |
| Group 2 | Men Women Total |
13 17 30 |
22.0 ± 5.9 21.5 ± 4.3 21.7 ± 5.0 |
18–39 18–37 18–39 |
| Group 3 | Men Women Total |
17 13 30 |
22.7 ± 4.7 22.7 ± 5.6 22.7 ± 5.0 |
18–38 18–38 18–38 |
| Group 4 | Men Women Total |
19 11 30 |
22.8 ± 6.0 21.3 ± 2.3 22.2 ± 4.9 |
18–42 19–25 18–42 |
| Group 5 | Men Women Total |
17 13 30 |
22.5 ± 5.4 21.9 ± 2.9 22.2 ± 4.5 |
18–42 18–30 18–42 |
| All groups | Men Women Total |
80 70 150 |
22.6 ± 5.2 22.0 ± 4.2 22.3 ± 4.7 |
18–42 18–39 18–42 |
Group 1 = gD-2t 40 μg, Group 2 = gD-2t 80 μg, Group 3 = gD-2t 20 μg, Group 4 = gD-2t 20 μg, Group 5 = gD-2t 20 μg; N, number of subjects in a given category; SD, standard deviation.